Ftse Mib
34.108,76
-0,78%
DAX
18.495,19
-0,56%
S&P 500
5.631,22
0,28%
NASDAQ
18.472,57
0,40%
Bitcoin
62.748,30
-3,25%
Registration Strip Icon for alerts Registrati per avvisi in tempo reale, portafoglio personalizzato e movimenti di mercato.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ AbCellera Biologics Inc (ABCL) AbCellera Biologics Inc (ABCL) Notizie

ABCL

AbCellera Biologics (ABCL)

HOME News News di Agenzia

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:ABCL
DataOraFonteTitoloSimboloCompagnia
22/06/202115:00Business WireAbCellera Continues Expansion & Strengthens Future Pandemic Preparedness with First-of- its-Kind GMP Manufacturing Facility f...NASDAQ:ABCLAbCellera Biologics Inc
21/06/202122:33Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ABCLAbCellera Biologics Inc
10/06/202123:18Edgar (US Regulatory)Securities Registration Statement (s-1)NASDAQ:ABCLAbCellera Biologics Inc
10/06/202123:11Business WireAbCellera Announces Secondary Private Sale of 11.9 Million Common SharesNASDAQ:ABCLAbCellera Biologics Inc
10/06/202123:02Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ABCLAbCellera Biologics Inc
17/05/202122:07Edgar (US Regulatory)Amended Current Report Filing (8-k/a)NASDAQ:ABCLAbCellera Biologics Inc
15/05/202102:48Business WireCORRECTING and REPLACING AbCellera Reports Q1 2021 Business ResultsNASDAQ:ABCLAbCellera Biologics Inc
14/05/202122:07Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:ABCLAbCellera Biologics Inc
13/05/202122:05Business WireAbCellera Reports Q1 2021 Business ResultsNASDAQ:ABCLAbCellera Biologics Inc
11/05/202122:05Business WireAbCellera to Present Virtually at Berenberg Conference on May 18, 2021NASDAQ:ABCLAbCellera Biologics Inc
06/05/202115:00Business WireAbCellera Partners with Angios to Develop Therapeutics to Combat Blindness Caused by Diabetic RetinopathyNASDAQ:ABCLAbCellera Biologics Inc
04/05/202112:30Business WireNew AbCellera-Discovered Antibody that Neutralizes Viral Variants of COVID-19, LY-CoV1404, Enters Clinical TrialsNASDAQ:ABCLAbCellera Biologics Inc
29/04/202122:10Business WireAbCellera Breaks Ground on Global Headquarters in Vancouver and Expects to Hire Hundreds of Scientific and Tech ProfessionalsNASDAQ:ABCLAbCellera Biologics Inc
28/04/202122:04Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:ABCLAbCellera Biologics Inc
21/04/202122:05Business WireAbCellera to Report First Quarter 2021 Financial Results on May 13, 2021NASDAQ:ABCLAbCellera Biologics Inc
14/04/202122:05Business WireAbCellera and Empirico Announce Strategic Multi-Target Antibody Discovery CollaborationNASDAQ:ABCLAbCellera Biologics Inc
12/04/202122:05Business WireAbCellera to Present Virtually at Upcoming Investor ConferencesNASDAQ:ABCLAbCellera Biologics Inc
05/04/202120:00Business WirePublished Peer-Reviewed Data Demonstrate Bamlanivimab’s High Potency Against SARS-CoV-2 & Support its Use as a Foundational...NASDAQ:ABCLAbCellera Biologics Inc
01/04/202116:37Dow Jones NewsAbCellera Biologics Up; Expands Agreement With GileadNASDAQ:ABCLAbCellera Biologics Inc
01/04/202115:00Business WireAbCellera and Gilead Sciences Announce New Multi-Year, Multi-Target Antibody Discovery CollaborationNASDAQ:ABCLAbCellera Biologics Inc
31/03/202100:07Edgar (US Regulatory)Annual Report (10-k)NASDAQ:ABCLAbCellera Biologics Inc
29/03/202122:05Business WireAbCellera Reports Full Year 2020 Business ResultsNASDAQ:ABCLAbCellera Biologics Inc
10/03/202118:32Dow Jones NewsAbCellera Posts Positive Results For Advanced Covid-19 Treatment TrialNASDAQ:ABCLAbCellera Biologics Inc
10/03/202117:21Business WireAbCellera-Discovered Bamlanivimab Together with Etesevimab Reduced Hospitalizations & Prevented Death in Phase 3 Trial for Ea...NASDAQ:ABCLAbCellera Biologics Inc
05/03/202123:00Dow Jones NewsAbCellera's Covid-19 Treatment Gets Recommendation From European RegulatorsNASDAQ:ABCLAbCellera Biologics Inc
05/03/202121:30Business WireEMA Advises Use of AbCellera-Discovered Bamlanivimab, Alone or Together with Etesevimab, to Treat Confirmed COVID-19 PatientsNASDAQ:ABCLAbCellera Biologics Inc
17/02/202122:05Business WireAbCellera to Present at the SVB Leerink Global Healthcare ConferenceNASDAQ:ABCLAbCellera Biologics Inc
16/02/202122:38Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:ABCLAbCellera Biologics Inc
16/02/202112:38Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:ABCLAbCellera Biologics Inc
11/02/202122:05Business WireAbCellera Appoints Ester Falconer, Ph.D., as Chief Technology OfficerNASDAQ:ABCLAbCellera Biologics Inc
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:ABCL

La tua Cronologia

BIT
P258S1
NLBNPIT258S1 20991231 77...
LSE
AZ44
Aberforth Split Level In...
NYSE
BWA
BorgWarner
NASDAQ
NUWE
Newellis
Delayed Upgrade Clock
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network